Novartis AG

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.83%158.240.7%$1178.24m
MRKMerck & Co., Inc. 0.20%76.600.7%$1002.12m
PFEPfizer Inc. 0.08%37.200.9%$1001.79m
ABBVAbbVie, Inc. -1.08%107.031.9%$822.28m
BMYBristol-Myers Squibb Co. -0.38%63.371.0%$730.48m
LLYEli Lilly & Co. 0.38%183.201.1%$689.46m
AZNAstraZeneca Plc 1.57%49.961.2%$438.81m
GSKGlaxoSmithKline Plc 0.33%36.160.2%$182.22m
RPRXRoyalty Pharma Plc 0.00%41.430.2%$160.14m
NVSNovartis AG -0.05%86.580.2%$151.28m
VTRSViatris, Inc. 0.85%13.080.0%$128.86m
RGENRepligen Corp. 0.00%212.866.8%$92.84m
CVACCureVac NV 3.66%99.150.0%$77.32m
ATNF180 Life Sciences Corp. 2.60%11.070.0%$65.97m
SNYSanofi 0.64%50.480.2%$60.76m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.